Allex
Active Substance: desloratadine
Common Name: desloratadine
ATC Code: R06AX27
Marketing Authorisation Holder: Schering-Plough Europe
Active Substance: desloratadine
Status: Withdrawn
Authorisation Date: 2001-01-15
Therapeutic Area: Urticaria
Rhinitis, Allergic, Seasonal
Rhinitis, Allergic, Perennial
Pharmacotherapeutic Group: Antihistamines for systemic use
Therapeutic indication
Aerius is indicated for the relief of symptoms associated with:
- allergic rhinitis (see section 5.1)
- urticaria (see section 5.1)
The marketing authorisation for Allex has been withdrawn at the request of the marketing authorisation holder.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
